Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States, with more than $380 billion in assets under management and administration (AUMA). Its quarterly results matter because they offer a direct read on annuity demand, spread income, and capital return in the life and retirement insurance sector. The company has been working to grow its fee-based and spread-based businesses while returning capital to shareholders, even as interest-rate changes and transactional activity create quarter-to-quarter volatility. This report also lands against the backdrop of Corebridge's pending merger with Equitable Holdings, making investor attention on margins, deposits, and capital strength especially high.
Corebridge Financial reported third-quarter 2026 net income available to common shareholders of $1.4 billion, or $3.22 per diluted share, compared with $144 million, or $0.27 per share, in the same period a year ago. The jump primarily reflected favorable net realized gains, including items tied to the Fortitude Re funds withheld embedded derivative and fair-value market risk benefits. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
On an operating basis, the company posted adjusted after-tax operating income (AATOI) of $545 million and operating earnings per common share of $1.22, up 27% from $0.96 a year earlier and roughly in line with analyst consensus. Adjusted pre-tax operating income (APTOI) was $677 million, up 4% year over year.
Premiums and deposits were $8.8 billion, a 29% decline from $12.29 billion a year ago; excluding transactional activity such as PRT and GICs, the decline was 19%. Segment results were mixed: Individual Retirement APTOI rose 3% to $466 million, and Institutional Markets APTOI climbed 48% to $198 million, while Group Retirement APTOI fell 11% to $164 million and Life Insurance APTOI declined 32% to $17 million.
Corebridge reported results after the market close on November 2, 2026, with a conference call scheduled for the following morning. The headline picture is a study in contrasts: GAAP (generally accepted accounting principles) earnings per share surged far above expectations, while revenue came in below consensus, and the company's own operating earnings per share landed in line with estimates. Investors are likely to weigh the strong annuity sales momentum and capital return against the pronounced decline in premiums and deposits, much of which stemmed from lower fixed index annuity sales and reduced transactional activity. The pending Equitable merger also frames sentiment, as the market evaluates cost-savings potential and execution risk through the regulatory approval process.
Looking ahead, investors should watch how Corebridge sustains its annuity sales momentum, particularly in fixed index annuities and registered index-linked annuities (RILAs), which have been key growth areas. Management pointed to the strongest annuity sales quarter of the year, and continued demand could help offset softer fixed annuity volumes.
The company's spread income and fee income trends will also be in focus. Interest-rate movements affect base spread income, and the annual actuarial assumption update weighed on APTOI this quarter, so the trajectory of investment yields and fee-based product growth remains important.
Capital management is another key monitor. Corebridge returned $295 million to shareholders during the quarter through buybacks and dividends, and investors will look for signs that the capital position supports continued repurchases while the merger progresses.
Finally, the pending merger with Equitable Holdings is a central catalyst. With more than $100 million in identified cost savings and the regulatory approval process underway, updates on deal timing, integration planning, and expense synergies will likely drive sentiment in the quarters ahead.
In my view, tools like Tickeron’s AI Screener can help investors quickly compare earnings-driven names such as CRBG against peers in the insurance and financial sectors. I often turn to it when scanning for technical patterns, fundamentals, and AI signals around quarterly reports to get a clearer sense of relative positioning without manual effort. This approach keeps my research efficient while highlighting potential comparables worth watching.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CRBG advanced for three days, in 186 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on CRBG as a result. In 54 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 54 cases where CRBG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 54%.
The Moving Average Convergence Divergence Histogram (MACD) for CRBG turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 25 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRBG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
CRBG broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CRBG entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CRBG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.538) is normal, around the industry mean (2.420). P/E Ratio (22.462) is within average values for comparable stocks, (-3.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.029) settles around the average of (0.268) among similar stocks. P/S Ratio (0.896) is also within normal values, averaging (15.694).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRBG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers